- Factors associated with treatment escalation among MS specialists and general neurologists: Results from an International cojoint study2022 | First Faculty of Medicine
- Adalimumab versus infliximab in pediatric patients with Crohn's disease: A propensity-score analysis and predictors of treatment escalation2022 | Second Faculty of Medicine
- Fingolimod in clinical practice: case reports2014 | Publication without faculty affiliation
- Personalization of neo/adjuvant treatment of HER2-positive breast cancer is the key to achieve the best results2022 | First Faculty of Medicine
- Dimethyl fumarate and escalation therapy2017 | Faculty of Medicine in Hradec Králové
- Escalation therapy in multiple sclerosis2016 | Faculty of Medicine in Hradec Králové
- Clinical Features and Natural History of Paediatric Patients with Ulcerative Proctitis: A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN2023 | Second Faculty of Medicine
- Evolution of Brain Volume Loss Rates in Early Stages of Multiple Sclerosis2021 | First Faculty of Medicine
- Glatirameracetate - the treatment of multiple sclerosis monitored in the ReMuS Registry2020 | Faculty of Medicine in Pilsen
- Does the development of new drugs for multiple sclerosis change the prognosis of the patient?2011 | First Faculty of Medicine
- Timing of high-efficacy therapy in relapsing-remitting multiple sclerosis: A systematic review2017 | First Faculty of Medicine
- Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later2016 | First Faculty of Medicine
- Left ventricular reverse remodelling and its predictors in non-ischaemic cardiomyopathy2022 | Publication without faculty affiliation
- Effect of desire for pregnancy on decisions to escalate treatment in multiple sclerosis care: Differences between MS specialists and non-MS specialists2022 | First Faculty of Medicine
- The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements2020 | Publication without faculty affiliation
- Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial2021 | First Faculty of Medicine